![]() ![]() ![]() ResultsĬriterion validity was supported by good to excellent correlations between Eforto® and MV for GS ( r = 0.95) and muscle fatigability (FR r = 0.81 and GW r = 0.73), and no significant differences in measurements between both systems. In hospitalized participants, fatigability was tested twice using Eforto®, once by a researcher and once by a health professional. In community dwellers fatigability was tested twice in the clinic (once with Eforto®, once with Martin Vigorimeter (MV), standard analog handgrip system) and for six consecutive days as a self-assessment at home with Eforto®. MethodsĬommunity-dwelling older persons ( n = 61), geriatric inpatients ( n = 26) and hip fracture patients ( n = 25) were evaluated for GS and muscle fatigability. ![]() The aim was to evaluate the validity and reliability of Eforto® to measure muscle fatigability. The Eforto® system consists of a rubber bulb that is wirelessly connected to a smartphone-based application, and a telemonitoring platform. We developed Eforto®, an innovative system for (self-)monitoring of grip strength (GS) and muscle fatigability (Fatigue Resistance (FR = time until GS decreased to 50% of maximum during sustained contraction) and grip work (GW = area under the strength-time curve)). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |